Guru Ownership Trend
Guru Analysis for MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics (MLTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $40.98 M.
Top institutional holders include Steven Cohen and Jefferies Group.
Institutional sentiment is currently Bullish. This is evidenced by a $13.23 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 105.8%. Conversely, Paul Tudor Jones reduced exposure by 40.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for MoonLake Immunotherapeutics (MLTX)
Major holders include Steven Cohen ($25.51 M), Jefferies Group ($9.32 M), Renaissance Technologies (RenTech) ($5.16 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.25 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $13.23 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited MLTX. The total reported sell value was $781,742.77.
Yes, 0 managers opened new positions in MLTX, and 3 increased their existing holdings. The total reported buy value was $14.01 M.